DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Bachert C. et al
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
Lancet (London, England) 2019;
394 10209 1638-1650
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.